Aflibercept for central retinal vein occlusion: an ongoing revolution or are we spinning in place?
Publication
, Other
Hahn, P; Fekrat, S
Published in: Am J Ophthalmol
March 2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am J Ophthalmol
DOI
EISSN
1879-1891
Publication Date
March 2013
Volume
155
Issue
3
Start / End Page
415 / 417.e2
Location
United States
Related Subject Headings
- Retinal Vein Occlusion
- Recombinant Fusion Proteins
- Receptors, Vascular Endothelial Growth Factor
- Ophthalmology & Optometry
- Male
- Macular Edema
- Humans
- Female
- Angiogenesis Inhibitors
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Hahn, P., & Fekrat, S. (2013). Aflibercept for central retinal vein occlusion: an ongoing revolution or are we spinning in place? Am J Ophthalmol. United States. https://doi.org/10.1016/j.ajo.2012.10.015
Hahn, Paul, and Sharon Fekrat. “Aflibercept for central retinal vein occlusion: an ongoing revolution or are we spinning in place?” Am J Ophthalmol, March 2013. https://doi.org/10.1016/j.ajo.2012.10.015.
Hahn P, Fekrat S. Aflibercept for central retinal vein occlusion: an ongoing revolution or are we spinning in place? Vol. 155, Am J Ophthalmol. 2013. p. 415-417.e2.
Hahn, Paul, and Sharon Fekrat. “Aflibercept for central retinal vein occlusion: an ongoing revolution or are we spinning in place?” Am J Ophthalmol, vol. 155, no. 3, Mar. 2013, pp. 415-417.e2. Pubmed, doi:10.1016/j.ajo.2012.10.015.
Hahn P, Fekrat S. Aflibercept for central retinal vein occlusion: an ongoing revolution or are we spinning in place? Am J Ophthalmol. 2013. p. 415-417.e2.
Published In
Am J Ophthalmol
DOI
EISSN
1879-1891
Publication Date
March 2013
Volume
155
Issue
3
Start / End Page
415 / 417.e2
Location
United States
Related Subject Headings
- Retinal Vein Occlusion
- Recombinant Fusion Proteins
- Receptors, Vascular Endothelial Growth Factor
- Ophthalmology & Optometry
- Male
- Macular Edema
- Humans
- Female
- Angiogenesis Inhibitors
- 1117 Public Health and Health Services